From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia
 | B Value | Wald | Odds Ratio | 95% C.I. Lower | For OR Upper | P Value |
---|---|---|---|---|---|---|
Age | 0.023 | 4.109 | 1.024 | 1.001 | 1.047 | 0.043* |
BMI | -0.001 | 0.006 | 0.999 | 0.967 | 1.031 | 0.940 |
NIH Stroke Scale | -0.120 | 7.713 | 0.887 | 0.815 | 0.965 | 0.005* |
Risk of Mortality GWTG | 0.068 | 1.518 | 1.070 | 0.961 | 1.193 | 0.218 |
Race | 0.108 | 0.147 | 1.115 | 0.640 | 1.940 | 0.701 |
Atrial Fibrillation | 0.387 | 1.295 | 1.473 | 0.756 | 2.871 | 0.255 |
Coronary Artery Disease | 0.404 | 1.910 | 1.498 | 0.845 | 2.655 | 0.167 |
Carotid Artery Stenosis | 1.955 | 6.145 | 7.063 | 1.506 | 33.134 | 0.013* |
Diabetes | 1.001 | 3.377 | 2.720 | 0.936 | 7.909 | 0.066 |
Congestive Heart Failure | 0.216 | 0.331 | 1.242 | 0.594 | 2.596 | 0.565 |
Hypertension | -0.049 | 0.010 | 0.952 | 0.369 | 2.456 | 0.919 |
Previous Stroke | 0.682 | 5.820 | 1.978 | 1.136 | 3.442 | 0.016* |
Previous TIA | -0.338 | 0.686 | 0.713 | 0.320 | 1.588 | 0.407 |
Peripheral Vascular Disease | -0.356 | 0.688 | 0.700 | 0.302 | 1.625 | 0.407 |
History of Smoking | -0.296 | 0.745 | 0.744 | 0.379 | 1.458 | 0.388 |
Antiplatelet medication | -0.043 | 0.024 | 0.958 | 0.556 | 1.650 | 0.877 |
Antihypertensive medication | -1.057 | 5.572 | 0.347 | 0.144 | 0.836 | 0.018* |
Cholesterol Reducer | -0.182 | 0.384 | 0.834 | 0.469 | 1.482 | 0.535 |
Antidiabetic medication | -0.627 | 1.236 | 0.534 | 0.177 | 1.613 | 0.266 |